27(4):921 to 930., Review article by the founder of the field
The clearest answer to date comes from a Phase 2 trial published in the New England Journal of Medicine in 2023, which reported 24.2% weight loss after 48 weeks at the highest dose in 338 adults with obesity but no other complications
This is modern, accessible weight loss designed for busy Tennessee professionals, parents, and anyone who wants doctor-guided fat reduction without in-office visits
A Holistic Approach: Semaglutide GLP-1 is integrated into a comprehensive weight management program that includes nutritional counseling, lifestyle modifications, and medical interventions
Who Is Oral GLP-1 Best For
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum